Devex
•
10th December 2020
Devex World 2020: The COVID catalyst: Innovating Across Sectors for Improved Access to Vaccines
Ronald T. Piervincenzi, CEO of USP, says every COVID-19 vaccine produced will require different storage conditions, delivery volumes, and numbers of doses, creating a lot of complexity for the health care worker and the pharmacist on the front-lines of delivery.
Such challenges, although surmountable, could jeopardize the speed of rollout, he says, adding that if equitable access to a vaccine — specifically to low- and middle-income countries — isn’t seen in the early part of 2021, pressure will become severe.
According to the People's Vaccine Alliance, if more isn’t done to ensure there are enough doses, 9 in 10 people may not be vaccinated in up to 70 lower-income countries next year.